Anthony M. Heagerty
UK
Pavel Hamet, O.Q., MD, PhD, FRCPC, FAHA, FRSM, FCAHS Dr. Hamet is the Canada Research Chair in Predictive Genomics. He is Professor of Medicine at Université de Montréal and of Experimental Medicine at McGill University, as well as a Visiting Professor at the First Faculty of Medicine at Charles University, Prague, Czech Republic. He is currently Chief of Gene Medicine Services and Director of the Laboratory of Molecular Medicine at the CHUM. He is also Director of Medical affairs for CART@GENE project and President of the International Society of Pathophysiology and of two biotech companies, Prognomix and Medpharmgene. He has received many honours from American Heart Association, Canadian Cardiovascular Society, Hypertension Canada, Japan Vascular Disease Research Foundation Society, Czech Academy of Science and Societé Francophone de Diabéte. He received Wilder Penfield Award and National Order from Québec Government for which he serves as Commissioner of Ethics in Science and Technology
